Pharvaris PHVS
NASDAQ PHVS
$35.25 -0.41 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Pharvaris (PHVS) Other Working Capital Changes (2021 - 2026)

Pharvaris' (PHVS) quarterly Other Working Capital Changes came in at -$72017.2 in Q1 2026, up 34.51% YoY from -$53542.3 in Q1 2025, and up 6.71% on a QoQ basis from -$77194.7 in Q4 2025.

Analysis

Pharvaris (PHVS) Other Working Capital Changes (2021 - 2026) Analysis & Trends

Pharvaris (PHVS) has 5 years of Other Working Capital Changes data on file, last reported at -$72017.2 in Q1 2026.

  • Quarterly Other Working Capital Changes rose 34.51% year-over-year to -$72017.2 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$204652.8 (up 8.77% YoY) and the FY2025 annual result came in at -$247443.3, down 43.19% from the prior year.
  • Other Working Capital Changes climbed to -$72017.2 in Q1 2026, from -$77194.7 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $5285.8 billion in Q3 2023 to a low of -$5287.4 billion in Q2 2023.
  • A 5-year average of -$95.6 million and a median of $234668.8 in 2025 frame the typical range for Other Working Capital Changes.
  • The widest YoY moves for Other Working Capital Changes: up 270653106.85% in 2023, down 432447935.2% in 2023.
  • Tracing PHVS's Other Working Capital Changes over 5 years: stood at -$47142.6 in 2022, then decreased by 24.74% to -$58805.5 in 2023, then surged by 51.7% to -$28403.3 in 2024, then slumped by 171.78% to -$77194.7 in 2025, then increased by 6.71% to -$72017.2 in 2026.
  • The last three Other Working Capital Changes figures came in at -$72017.2 (Q1 2026), -$77194.7 (Q4 2025), and -$29100.1 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Pharvaris 2.10 Bn 1.73 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.15 Mn
Jun 30, 2026 3.15 Mn
Mar 31, 2026 -1.44 Mn
Mar 31, 2026 -1.44 Mn
Dec 31, 2025 234,668.84
Dec 31, 2025 234,668.84
Sep 30, 2025 2.25 Mn
Sep 30, 2025 2.25 Mn
Jun 30, 2025 1.03 Mn
Jun 30, 2025 1.03 Mn
Mar 31, 2025 -1.36 Mn
Mar 31, 2025 -1.36 Mn
Dec 31, 2024 -1.50 Mn
Dec 31, 2024 -1.50 Mn
Sep 30, 2024 329.84 Bn
Sep 30, 2024 329.84 Bn
Jun 30, 2024 -323.43 Bn
Jun 30, 2024 -323.43 Bn
Mar 31, 2024 -2.19 Mn
Mar 31, 2024 -2.19 Mn